New psoriasis drug goes Head-to-Head with established treatment
NCT ID NCT06630559
Summary
This study is testing whether a new psoriasis medication called CT-P55 works as well as an already approved drug called Cosentyx. Researchers are comparing both treatments in 153 people with moderate to severe plaque psoriasis. The goal is to see which treatment better reduces skin symptoms and improves quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLAQUE PSORIASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Rheumatology Clinic NZOZ Lecznica MAK-MED s.c.
Nadarzyn, Poland
Conditions
Explore the condition pages connected to this study.